Filing Details

Accession Number:
0001209191-15-055897
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-24 17:09:30
Reporting Period:
2015-06-22
Filing Date:
2015-06-24
Accepted Time:
2015-06-24 16:09:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626199 Nivalis Therapeutics Inc. NVLS Pharmaceutical Preparations (2834) 208969493
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595725 Rock Springs Capital Management Lp 650 South Exeter Street
Baltimore MD 21202
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-22 364,358 $0.00 364,358 No 4 C Indirect By Rock Springs Capital Master Fund LP
Common Stock Acquisiton 2015-06-22 200,000 $14.00 564,358 No 4 P Indirect By Rock Springs Capital Master Fund LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Rock Springs Capital Master Fund LP
No 4 P Indirect By Rock Springs Capital Master Fund LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series 2 Convertible Preferred Stock Disposition 2015-06-22 364,358 $0.00 364,358 $2.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The Series 2 Preferred Stock automatically converted into shares of common stock upon the closing of the initial public offering.
  2. This report is filed jointly by Rock Springs Capital Master Fund LP (the "Master Fund") and Rock Springs Capital Management LP (the "Management Fund"), both of which share beneficial ownership of more than 10% of the capital stock of the issuer. The Management Fund, as investment adviser to the Master Fund, has the power to vote and dispose of securities held by each of them and may be deemed to have beneficial ownership of the shares owned by the Master Fund. Kris Jenner, Mark Bussard and Graham McPhail are each managing directors of the Management Fund and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons. Each of Kris Jenner, Mark Bussard and Graham McPhail disclaims beneficial ownership of the securities of the issuer held by the Master Fund except to the extent of their pecuniary interest therein.